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Important patient characteristics differ prior
to total knee arthroplasty and total hip
arthroplasty between Switzerland and the
United States
Patricia D. Franklin1*, Hermes Miozzari2, Panayiotis Christofilopoulos2, Pierre Hoffmeyer2, David C. Ayers1 and
Anne Lübbeke2
Abstract
Background: Outcomes after total knee (TKA) and hip (THA) arthroplasty are often generalized internationally.
Patient-dependent factors and preoperative symptom levels may differ across countries. We compared preoperative
patient and clinical characteristics from two large cohorts, one in Switzerland, the other in the US.
Methods: Patient characteristics were collected prospectively on all elective primary TKAs and THAs performed at a
large Swiss hospital and in a US national sample. Data included age, sex, education level, BMI, diagnosis, medical
co-morbidities, PROMs (WOMAC pain/function), global health (SF-12).
Results: Six thousand six hundred eighty primary TKAs (US) and 823 TKAs (Swiss) were evaluated. US vs.
Switzerland TKA patients were younger (mean age 67 vs. 72 years.), more obese (BMI ≥30 55% vs. 43%), had higher
levels of education, more cardiac disease. Swiss patients had lower preoperative WOMAC pain scores (41 vs. 52) but
pre-operative physical disability were comparable. 4,647 primary THAs (US) and 1,023 THAs (Swiss) were evaluated.
US vs. Switzerland patients were younger (65 vs. 68 years.), more obese (BMI ≥30: 38% vs. 24%), had higher levels of
education, more diabetes. Swiss patients had lower preoperative WOMAC pain scores (40 vs. 48 points). Physical
disability was reported comparable, but Swiss patients indicated lower mental health scores.
Conclusion: We found substantial differences between US and Swiss cohorts in pre-operative patient characteristics
and pain levels, which has potentially important implications for cross-cultural comparison of TKA/THA outcomes.
Reports from national registries lack detailed patient information while these data suggest the need for adequate
risk adjustment of patient factors.
Background
Osteoarthritis (OA) of the knee and hip are the most
rapidly rising musculosketetal conditions among adults
as reflected in the increasing demand for total knee and
hip arthroplasties (TKA and THA, respectively) [1, 2].
In the future the prevalence of OA is expected to rise
even further due to increases in life expectancy, aging
populations, and obesity [3]. OA places a high financial
burden on the health care system through costs for
medical and surgical treatment, adaptive aids and de-
vices, and time off from work [4]. Reducing OA
incidence and progression and improving its treatment
are considered urgent public health priorities [5].
Total joint arthroplasty (TJA) is currently the most ef-
fective treatment of endstage hip and knee OA. Because
surgeons use similar implants internationally, the out-
comes of TKA and THA, including patient-reported
outcome measures (PROMs), complication rates, and
implant survival, are often generalized across countries.
Existing research has shown that these outcomes are in
part dependent on the patient’s preoperative characteris-
tics [6–14]. However, patient dependent factors can
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differ considerably between countries and continents,
possibly leading to differences in results and national re-
vision burden. National TJA outcome registries often
lack detailed patient information, especially BMI, co--
morbidities, socio-economic status, pain, and level of
function. In addition, few studies have compared these
variables between different countries [7, 15–18]. Most of
these papers focused primarily on variations in preopera-
tive pain and function, four included data from both US
and European institutions [7, 15, 17, 18] and addressed ei-
ther knee or hip patients. A more complete understanding
of the similarities and differences in TKA and THA pa-
tients is required to guide risk-adjustment methods when
making cross-cultural outcome comparisons.
Our objective was to describe and compare preopera-
tive TKA and THA patient characteristics from two
large prospective cohorts, one in Switzerland (CH) and
the other in the United States (US). If significant differ-
ences in patient risk factors are detected, this will
support the need for risk-adjustment prior to future
international comparisons of outcomes.
Methods
Study participants and study design
Patient characteristics were collected prospectively on all
elective primary TKAs and THAs performed (1) at a
large University hospital in Geneva, Switzerland between
January 2010 and December 2012 and (2) in FORCE-
TJR, a diverse, national sample of more than 130 sur-
geons in the US between May 2011 and December 2012.
Cohort from Switzerland
Swiss patients included in this study are part of two
registries at the Division of Orthopaedic and Trauma
Surgery of the Geneva University Hospitals, Geneva,
Switzerland: (1) the THA registry prospectively enrolling
all patients undergoing THA since 1996; and (2) the
TKA registry prospectively enrolling all patients under-
going THA since 1998. The registries are approved by
the local Ethics committee. The institution is one of the
largest Orthopaedic and Trauma Surgery centers in
Switzerland and the only public hospital of the Canton
Geneva serving a population of 500,000 inhabitants. The
institution treats patients with public insurance (about
85% of the patients operated upon for TJA) as well as
those with private insurance (about 15%). Switzerland
has universal compulsory health care coverage. The
patients in the two registries were comparable in age
and sex-distribution to the Swiss population undergoing
hip or knee replacement [19–21].
Cohort from the United States
FORCE-TJR (Function and Outcomes Research for
Comparative Effectiveness in Total Joint Replacement) is
a prospective, national total joint arthroplasty (TJA) co-
hort centered at the University of Massachusetts Med-
ical School. Patients are enrolled from more than 130
orthopedic practices distributed across 22 states in the
United States with diverse geography (e.g. urban/rural),
ownership (e.g., HMO, private practice, and academic
settings), and varied surgical volume to ensure inclusion
of diverse patients and surgeon practices [22]. Participat-
ing surgeons identify consecutive TJA patients and the
FORCE-TJR staff collect pre- and post-operative data.
Patient demographic and clinical profiles parallel current
US experience when compared to the most recent
Healthcare Utilization Project (HCUP) data. FORCE-TJR
obtained Institutional Review Boards (IRBs) approval,
and patients provide informed consent. Participating
surgeons also submit data detailing surgical implant de-
tails, surgical technique, operative data, hospitalization
data, and patients report pain and functional outcome
data at standard post-operative intervals. For simplicity,
the FORCE-TJR cohort will be referred to as the US cohort.
Patient characteristics, patient-reported outcome mea-
sures, and data collection
In Switzerland, information on baseline patient character-
istics (exposure) was obtained preoperatively on: age at
operation; sex; education level (years of schooling in three
categories); Body Mass Index (BMI); diagnosis (primary or
secondary osteoarthritis as defined by the surgeon); and
medical co-morbidities (diabetes, cardiac disease and
stroke) were routinely obtained from the anaesthesia re-
port and discharge summary. In the US, these same data
were recorded at the time surgery was scheduled based
upon the patient-report and surgeon records. The US
registry did not record secondary osteoarthritis.
Patient-reported outcome measures (PROMS; out-
comes) were obtained by questionnaires sent to the
patients 14 days (Swiss) and 1–2 months (US) prior to
surgery. Geneva used a reduced form of the Western
Ontario McMaster Universities (WOMAC) pain and
function [23] and a global health questionnaire, the 12-
item short-form health survey (SF-12). The US estimated
the WOMAC pain and function scores from the routinely
collected (hip disability and osteoarthritis outcome score
(HOOS) and Knee injury and Osteoarthritis Outcome Score
(KOOS) sub-scores [24] and the 36-item short-form health
survey (SF-36) physical and mental component scores [25]
were collected. Higher scores on both the WOMAC and SF
indicate less pain and better function/health.
Data missingness was assessed in both cohorts.
Complete data were available for 80% of patients in the
Swiss cohort and 92% for the US. The one exception
was education level because education was not assessed
in the early years of the Swiss cohort, but was complete
in the later years.
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Statistical analysis
We calculated differences in proportions and their 95%
confidence intervals (CI) to compare categorical vari-
ables, and mean differences and 95% CIs to compare
continuous variables. In addition, preoperative score dif-
ferences were assessed using effect sizes. Effect sizes
were calculated as mean unadjusted difference divided
by the pooled SD of the corresponding mean scores.
Effect sizes of 0.2, 0.5, and 0.8 are regarded as small,
medium, and large degrees of difference, respectively
[26]. For the WOMAC instrument an effect size ≥ 0.25
or effects > 6% of the maximal score have been consid-
ered as the minimal clinically important difference [27].
To illustrate variability in key measures, density plots
were generated using STATA version 12 to compare US
and Swiss distributions of age, BMI, and pre-TKA and
THA pain and function. Scatter plots and lines of best
fit display correlations between BMI and age, and pre-
TKA and THA pain and function in the US and
Switzerland as well as correlations between emotional
health (Short Form health survey, Mental Component
Summary; SF-MCS) and pre-TKA and THA pain and
function. Pain and Function stratified by education were
illustrated with bar graphs. Finally, we used linear re-
gression with country as an indicator variable to assess
differences by country in the associations between age,
BMI, education, and MCS and pre-operative pain and
function.
Results
Overall, 6,680 primary TKAs from the US cohort and
823 primary TKAs from the Swiss cohort were included
(see baseline characteristics: Table 1, categorical vari-
ables and Table 2, continuous variables), as well as 4,647
primary THAs from the US cohort and 1,023 primary
THAs from the Swiss cohort (see baseline characteris-
tics: Table 3, categorical variables and Table 4, continu-
ous variables). Over the same time period, in the US
registry more TKAs than THAs were implanted, which
parallels relative TKA-THA utilization nationally,
whereas in the Swiss cohort there were more THAs than
TKAs.
Between-cohort comparison of baseline characteristics
prior to knee arthroplasty
Patients undergoing primary TKA in the US compared
to those in Switzerland were significantly younger (mean
age 67 vs. 72 years.; <60 years: 22% vs. 9%, p < .0001).
The mean BMI differed between the two registries (31.5
vs. 29.6 kg/m2) with the US having significantly more
obese class I (BMI 30-34.9: 29% vs. 26%, p < .0001) and
class II patients (BMI ≥35: 26% vs. 17%, p < .0001).
Table 1 Baseline characteristics of patients undergoing primary TKA for categorical variables
Geneva registry
Switzerland
(N = 823)
FORCE-TJR
United States
(N = 6,680)
Risk difference (95% CI) P-value****
Women (N, %) 567 (68.9) 4,142 (62.0) 6.9 (3.5; 10.3) 0.000
Age in categories (N, %) 0.000
<60 years of age 75 (9.1) 1,462 (21.9) -12.8 (-15.2; -10.5)
60 to 79.9 years of age 555 (67.4) 4,623 (69.3) -1.9 (-7.8; 4.1)
≥80 years of age 193 (23.5) 586 (8.8) 14.7 (11.3; 18.1)
Preoperative BMI categories (N, %)* 0.000
<25 177 (21.5) 832 (12.9) 8.6 (5.3; 11.9)
25–29.9 295 (35.8) 2,053 (31.8) 4.0 (-0.3; 8.3)
30–34.9 211 (25.6) 1,869 (29.0) -3.3 (-7.0; 0.4)
≥35 140 (17.0) 1,698 (26.3) -9.3 (-12.4; -6.2)
Education (N, %)** 0.000
<= 8 years 140 (41.1) 104 (1.6) 39.4 (32.6; 46.2)
9–12 years (high school) 110 (32.3) 2060 (32.3) 0.0 (-6.2; 6.2)
> = 13 years (college) 91 (26.7) 4216 (66.1) -39.4 (-45.2; -33.6)
Co-morbidities (N, %)
Diabetes 145 (17.6) 1,125 (16.8) 0.8 (-2.3; 3.8) 0.932
Cardiac disease 48 (5.8) 531 (7.9) -2.1 (-3.9; -0.3) 0.013
Stroke 24 (2.9) 209 (3.1) -0.2 (-1.5; 1.0) 0.545
Primary OA (N, %) 719 (87.4) 5,886 (88.1)*** -0.7 (-3.2; 1.7)
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Table 2 Baseline characteristics of patients undergoing primary TKA for continuous variables
Geneva registry
Switzerland
(N = 823)
FORCE-TJR
United States
(N = 6,680)
Mean difference
(95% CI)
P-value****
Age at operation, mean [±SD] 72.3 [±9.4] 66.7 [±9.4] 5.6 (4.9; 6.3) 0.000
Preoperative BMI, mean [±SD]* 29.6 [±5.9] 31.53 [±6.2] -1.9 (-1.5; -2.4) 0.000
Mean age in each BMI category, [±SD]
<25 72.9 [±10.9] 69.38 [±10.2] 3.5 (1.8; 5.2) 0.000
25–29.9 74.25 [±8.6] 68.51 [±9.4] 5.8 (4.6; 6.9) 0.000
30–34.9 71.02 [±8.8] 66.64 [±8.7] 4.4 (3.1; 5.6) 0.000
≥35 69.16 [±8.7] 63.29 [±8.5] 5.9 (4.4; 7.3) 0.000
Preoperative scores, mean [±SD] Mean difference
(95% CI)/Effect size
WOMAC pain 41.0 [±17.9] 51.59 [±19.0] -10.6 (-12.2; -9.1)/0.57 0.000
WOMAC function 44.82 [±19.2] 52.09 [±18.6] -7.3 (-8.9; -5.7)/0.39 0.000
SF-12 Physical Component Summary 34.45 [±7.6] 32.68 [±8.3] 1.8 (1.1; -2.5)/0.23 0.000
SF-12 Mental Component Summary 44.84 [±11.2] 51.40 [±12.3] -6.6 (-7.6; -5.5)/0.56 0.000
*BMI was available for 6,452 TKAs (96.6%) from FORCE-TJR
**In the Geneva cohort information on education was routinely collected only since 2012
***FORCE-TJR collects RA versus OA
****Pearson chi2 tests were used for categorical variables, and two-sample Wilcoxon rank-sum (Mann-Whitney) tests were used for continuous variables
Table 3 Baseline characteristics of patients undergoing primary THA for categorical variables
Geneva registry
Switzerland
(N = 1,023)
FORCE-TJR
United States
(N = 4,647)
Risk difference
(95% CI)
P-value****
Women (N, %) 590 (57.7) 2,660 (57.2) 0.5 (-2.9; 3.8) 0.788
Age in categories (N, %) 0.000
<60 years of age 231 (22.6) 1,435 (31.0) -8.4 (-11.8; -5.1)
60 to 79.9 years of age 599 (58.6) 2,813 (60.8) -2.2 (-7.4; 3.0)
≥80 years of age 193 (18.9) 380 (8.2) 10.7 (7.9; 13.4)
Preoperative BMI categories (N, %)* 0.000
<25 381 (37.5) 1,104 (24.3) 13.1 (9.1; 17.1)
25–29.9 397 (39.0) 1,692 (37.3) 1.7 (-2.5; 6.0)
30–34.9 173 (17.0) 1,056 (23.3) -6.3 (-9.2; -3.4)
≥35 66 (6.5) 683 (15.1) -8.6 (-10.5; -6.6)
Education (N, %)** 0.000
<= 8 years 126 (38.3) 36 (0.8) 37.5 (30.8; 44.2)
9–12 years (high school) 104 (31.6) 1134 (25.7) 5.9 (-0.4; 12.1)
> = 13 years (college) 99 (30.1) 3238 (73.5) -43.4 (-49.8; -36.9)
Co-morbidities (N, %)
Diabetes 98 (9.6) 543 (11.7) -2.1 (-4.2; 0.0) 0.017
Cardiac disease 80 (7.8) 330 (7.1) 0.7 (-1.2; 2.6) 0.610
Stroke 38 (3.7) 116 (2.5) 1.2 (0.0; 2.5) 0.050
Primary OA (N, %) 834 (81.5) 4,190 (90.2)*** -8.7 (-11.2; -6.1)
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Patients in the US reported cardiac disease more often,
despite a younger mean age. With respect to preopera-
tive scores, patients in the US had higher WOMAC pain
scores (52 vs. 41 points) indicating significant knee pain
in both countries, but less knee-specific pain at time of
TKA in the US. The effect size was clinically relevant
(0.57). While WOMAC function scores in both coun-
tries indicated significant impairment, knee-specific
function scores were higher in the US (52.1 vs. 44.8).
Pre-operative overall physical disability as measured by
the general health questionnaire (SF) was reported in
both countries, (Swiss 34.5 vs. US 32.7). The mental
component score of the SF was lower in the Swiss co-
hort (effect size 0.56).
Between-cohort comparison of baseline characteristics
prior to hip arthroplasty
Patients undergoing primary THA in the US compared
to those in Switzerland were significantly younger (mean
age 65 vs. 68 years.; <60 years: 31% vs. 23%, p < .0001).
The mean BMI differed between the two registries (29.1
vs. 26.9 kg/m2) with the US having more obese class I
(BMI 30-34.9: 23% vs. 17%, p < .0001) and class II pa-
tients (BMI ≥35: 15% vs. 7%, p < .0001). Patients in the
US had also more often diabetes, despite a younger
mean age. With respect to preoperative scores, patients
in the US had higher WOMAC pain scores (48 vs. 40
points) indicating less hip-specific pain at time of THA.
The effect size was clinically relevant (0.43). WOMAC
function scores were also higher in the US indicating
slightly less functional impairment due to hip OA.
Marked pre-operative overall physical disability on the
general health questionnaire (SF) was reported in both
countries,(US 31.3 vs. Swiss 33.4). The mental compo-
nent score of the SF was lower in the Swiss cohort
(effect size 0.50).
Between-cohort variation in age, BMI, education, MCS,
and pre-operative pain and function
Analyses of the variation in age, BMI, education, MCS,
and pre-operative pain and function found that similar
variation exists in both cohorts on each measure.
(Figures 1, 2, 3 and 4). However, the Swiss distributions
are shifted toward older age, lower BMI, lower education
level, lower MCS, and lower pain score (greater pain) for
both TKA and THA. In contrast, the pre-operative func-
tion score distributions are similar in both countries for
TKA and THA. In both TKA and THA, mean BMI was
higher in US patients than in Swiss patients across all
age groups. Within each BMI category, US TKA and
THA patients were substantially younger as compared
to the Geneva patients and the difference in BMI was
greatest in the youngest patients. (Tables 1, 2, 3 and 4).
Within-cohort correlations between age and pain and
function
Similar relationships existed between age and preopera-
tive pain and function for both TKA and THA. In TKA,
older age in both Swiss and US patients was associated
with less pre-operative pain and poorer function (lower
WOMAC scores) (Fig. 1a and c). For THA patients, US
patients with older age had less pain, but Swiss patients
Table 4 Baseline characteristics of patients undergoing primary THA for continuous variables
Geneva registry
Switzerland
(N = 1,023)
FORCE-TJR
United States
(N = 4,647)
Mean difference
(95% CI)
P-value****
Age at operation, mean [±SD] 68.2 [±12.9] 64.6 [±10.7] 3.6 (2.8; 4.3) 0.000
Preoperative BMI, mean [±SD]* 26.87 [±5.0] 29.12 [±5.7] -2.2 (-1.9; -2.6) 0.000
Mean age in each BMI category, [±SD]
<25 68.61 [±14.7] 66.35 [±11.5] 2.3 (3.7; 0.8) 0.000
25–29.9 68.55 [±12.2] 65.42 [±10.4] 3.1 (1.9; 4.3) 0.000
30–34.9 67.24 [±11.0] 63.82 [±10.1] 3.4 (1.8; 5.1) 0.000
≥35 65.68 [±8.8] 61.17 [±9.8] 4.5 (2.1; 7.0) 0.000
Preoperative scores, mean [±SD] Mean difference
(95% CI)/Effect size
WOMAC pain 39.51 [±18.5] 47.81 [±19.8] -8.3 (-9.8; -6.8)/0.43 0.000
WOMAC function 40.21 [±19.5] 44.24 [±19.2] -4.0 (-5.6; -2.5)/0.21 0.000
SF-12 Physical Component Summary 33.39 [±7.9] 31.26 [±8.5] 2.1 (1.5; 2.8)/0.26 0.000
SF-12 Mental Component Summary 43.91 [+11.7] 49.97 [±12.6] -6.1 (-7.0; -5.1)/0.5 0.000
*BMI was available for 6,452 TKAs (96.6%) from FORCE-TJR
**In the Geneva cohort information on education was routinely collected only since 2012
***FORCE-TJR collects RA versus OA
****Pearson chi2 tests were used for categorical variables, and two-sample Wilcoxon rank-sum (Mann-Whitney) tests were used for continuous variables
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Fig. 1 Association between Age and pre-THA/TKA pain/function among US (FORCE) and Swiss (Geneva) patients. Lower scores represent greater
pain/poorer function. a. association pre-TKA WOMAC pain; b. pre-THA WOMAC pain; c. pre-TKA WOMAC function; d. pre-THA WOMAC function.
The association between pain and age in (b). (THA) is significantly different between countries (P < 0.002)
Fig. 2 Association between BMI and and pre-THA/TKA pain/function among US (FORCE) and Swiss (Geneva) patients. Lower scores represent
greater pain/poorer function. a. association pre-TKA WOMAC pain; b. pre-THA WOMAC pain; c. pre-TKA WOMAC function; d. pre-THA WOMAC
function. The association between function and BMI in (c). (TKA) is significantly different between countries (P < 0.046)
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Fig. 3 Association between Education and pre-THA/TKA pain/function among US (FORCE) and Swiss (Geneva) patients. Lower scores represent
greater pain/poorer function. a. association pre-TKA WOMAC pain; b. pre-THA WOMAC pain; c. pre-TKA WOMAC function; d. pre-THA WOMAC
function. No statisticial difference between countries was detected for TKA or THA in the association between education and pain and function
Fig. 4 Association between emotional health (SFMCS) and pre-THA/TKA pain/function among US (FORCE) and Swiss (Geneva) patients. Lower
scores represent greater pain/poorer emotional health. a. association pre-TKA WOMAC pain; b. pre-THA WOMAC pain; c. pre-TKA WOMAC
function; d. pre-THA WOMAC function. No statisticial difference between countries was detected for TKA or THA in the association between
education and pain and function
Franklin et al. BMC Musculoskeletal Disorders  (2017) 18:14 Page 7 of 11
reported similar pain across ages (Fig. 1b). THA func-
tion was similar across all ages in both the US and Swiss
patients (Fig. 1d). No statistical difference was detected
between countries in the association between age and
pain and function for TKA. However, in THA, the
association with pain (not function) was significantly
different (p < 0.002) between countries.
Within-cohort correlations between BMI and pain and
function
In both the US and Swiss patients, higher BMI was asso-
ciated with greater pre-operative pain and poorer func-
tion (lower WOMAC scores) for both TKA and THA
(Fig. 2a-d). No statistical difference was detected
between countries in the association between BMI and
pain and function for THA. However, in TKA, the
association with function (not pain) was significantly
different (p < 0.05) between countries.
Within-cohort correlations between education and pain
and function
In both the US and Swiss patients, lower education was
associated with greater pre-operative pain (lower
WOMAC scores) for both TKA and THA (Fig. 3a-d).
Patients with less education also tended to have lower
function, however the association was much weaker than
for pain. No statisticial difference between countries was
detected for TKA or THA in the association between
education and pain and function.
Within-cohort correlations between emotional health and
pain and function
In both the US and Swiss patients, poorer emotional
health (low MCS) was correlated with greater pre-
operative pain and poorer function (Fig. 4a-d). This rela-
tionship was similar for both TKA and THA patients.
No statistical difference between countries was detected
for TKA or THA in the association between emotional
health and pain and function.
Discussion
At the time of primary total knee and hip arthroplasty,
clinically important differences in age, education level,
obesity prevalence, medical comorbidities, preoperative
pain levels and emotional health were observed between
the US and Swiss cohorts. The level of functional im-
pairment at the time of TKA and THA reflected signifi-
cant, and similar, disability in both countries. Because
existing research documents that implant longevity,
post-operative complication rates, and improvement in
pain and function after TJA vary by patient characteris-
tics, these data suggest that future cross-national TJA
outcome comparisons should address pre-TJA patient
differences prior to drawing conclusions [6–14].
Obesity is a well-known and important risk factor for
short- and long-term complications and a threat to pros-
thesis survival [8, 13]. The pattern and prevalence of
population obesity differs between the US and
Switzerland, especially among TKA patients, and the dif-
ferences have become more pronounced during the past
decade. Between 1999 to 2009, the “Bus Santé”, a large
cross-sectional population-based study in Geneva, re-
ported 35% of the population were overweight and 12%
obese [28]. The prevalence did not change during the 10
year time period [29]. In contrast, the corresponding
prevalences of overweight and obesity in the US were
34% and 30.5%, respectively, in 1999, and 33% and
35.7%, in 2009 [30]. The observed prevalences of obesity
among our TJA patients exceeded population-based
prevalences, both in Geneva and in the US. The differ-
ences were larger in TKA as compared with THA
patients. This finding parallels the understanding that
obesity is an important risk factor for OA, especially for
knee OA [31].
Obesity is also known to be associated with younger
age at the time TJA is performed [32]. We found that
the US TJA patients were substantially younger in every
BMI category as compared to the Geneva patients,
although the difference in age was highest in the greatest
BMI category. Thus, increased BMI may explain only
part of the observed age difference as reported previ-
ously [33, 34]. Other reasons for the younger age of the
US TJA patients may be related to cultural expectations
or health care access and delivery differences. Age is an
important factor influencing joint replacement out-
comes. Younger age increases the risk of prosthesis fail-
ure due to the generally more active lifestyle in younger
people [35]. Because of the substantially younger age in
the TKA and THA US cohorts there is an expected
greater proportion of patients still working and thus
likely exposing their arthroplasty to higher demands.
While patients in the US had greater BMI, the mean
pain score among TJA patients in the US was less than
the pain score reported in Switzerland. However, prior
research has documented that greater BMI is associated
with greater arthritis pain [36, 37]. This relationship
exists in these data as well. In both the US and Swiss
TKA and THA patients, higher BMI correlated with
more pain. TJA patients in both countries reported
similar, and substantial, functional limitations. Consist-
ent with previous reports, higher BMI was associated
with poorer function in both countries.
Only one study evaluated the association between edu-
cation and preoperative pain and function levels [15]
prior to TKA using the WOMAC score. In contrast to
our results they did not report an association. However,
Keurentjes et al. [38] using the SF-36 found lower pre-
operative scores in less educated THA and TKA
Franklin et al. BMC Musculoskeletal Disorders  (2017) 18:14 Page 8 of 11
patients. The discrepancy in education levels between
the US and Swiss cohorts may be exaggerated in this
study. The well-documented disparity in the use of TJA
in the US among minority patients [39–45] and those
with lower income and education will skew the educa-
tion level in this cohort toward a higher mean US
education [46]. In contrast, the proportion of patients
with tertiary education in the Swiss cohort was in ac-
cordance with the reported levels of education in 2012
in Switzerland (29% with tertiary education) based on
the annual OECD survey of adults aged 55–64 years
[47]. However, of importance, both cohorts illustrate a
significant association between lower education level
and greater pre-operative pain.
Despite the younger age in US patients, the prevalence
of comorbidities (diabetes- TKA, cardiac disease-THA)
was greater. Diabetes and cardiac disease are both asso-
ciated with obesity and with increased short-term post-
TJA complication rates [9, 11, 14]. However, researchers
have reported that medical comorbidities, in contrast to
other patient factors, are not key predictors of patient-
reported outcomes in THA [48]. In contrast to the pat-
tern in medical comorbidities, emotional health, as mea-
sured by the SF MCS, was substantially poorer in
Switzerland than in the US. However, a number of rea-
sons may explain this difference. First, population-based
normative values for the SF-12 MCS vary between the
two countries (US MCS norm 50 as compared to the
French-speaking area of Switzerland MCS norm 46.3,
[49] accounting for some of this difference. Second, the
poorer emotional health is possibly related to the greater
pain level among the Swiss patients, because higher
levels of OA pain have been associated with greater dis-
ability and depressed mood [50]. And third, patients
with lower socioecomonic status, who constitute a much
higher proportion in the Swiss as compared to the US
cohort, have been shown to report lower emotional
health [51]. The MCS differences are important as it has
been reported that patients with poorer pre-TJA emo-
tional health may be at risk for suboptimal postoperative
outcomes [7]. A multicomponent psychosocial support
program has been suggested prior to and following sur-
gery including consistent counselor support as well as
education and coping skills training to address anxiety,
pain management, depression and the role of social sup-
ports [42].
In summary, the greater prevalence of obesity and
medical comorbidities, plus a younger mean age, poten-
tially increase the risk for complications and revisions
among the US patients, as compared to the Swiss. How-
ever, the Swiss reported a much higher proportion of pa-
tients with a low level of education, higher pain levels
and poorer emotional health at the time of surgery.
These differences should be considered in future cross-
cultural comparisons of short and long-term outcomes
after TJA.
Few prior studies have evaluated differences in patient
risk factors across international patient groups. In 2004,
Lingard and colleagues evaluated the predictors of pain
relief and functional gain after TKA in the US, England,
and Australia [7]. While the researchers evaluated the
role of BMI, only pre-operative physical function, poor
emotional health, and greater medical comorbidities
were associated with poorer outcomes. In a study of 12
European countries with nearly all THA patients having
advanced radiographic hip OA, the level of pre-operative
pain, disability, and patient risks varied across countries
[44]. Another sample of TJA patients from 10 countries
found TJA patients had worse mean pain and function
scores than OA patients without TJA but there was sub-
stantial overlap in symptoms between the two groups,
and no consistent pain and function profile existed for
TJA patients across countries [17]. Gromov and col-
leagues reported that US THA patients had a younger
age and higher BMI in accordance with our findings,
however, they found greater pain and poorer function
than in the European patients [18]. Finally, Gordon and
colleagues report that patient predictors of pain and
function in THA performed similarly across two coun-
tries (Denmark and Sweden) [52].
Surgeons, policy makers, and implant manufacturers
rely on national registry reports for comparative implant
information. Registry reports as those from the Scandi-
navian countries, the United Kingdom, or Australia
present implant survival within age and sex sub-groups,
and identify differences in implant survival by these
patient attributes, While the United Kingdom, Sweden,
the Netherlands, and New Zealand implant registries are
now collecting PROMs [49–51, 53, 54] national regis-
tries do not yet adjust implant survival comparisons by
pre-operative function and/or comorbidities. Our data
document important differences in patient characteris-
tics between TKA and THA patients from different
countries. Future research will examine the impact of
these differences on TJA outcomes.
Limitations
While we carefully pre-defined measures to assure com-
parable data, there are possible measurement limitations.
First, both countries are dependent upon documentation
practices for medical comorbidities and it is possible that
the difference between the US and Switzerland is related
to differences in documentation. For example, the US
database lacked documentation of secondary OA, while
the Swiss registry was able to differentiate primary and
secondary OA. Second, different methods were used to
collect and score patient-reported outcomes (SF12 vs
SF36; WOMAC vs HOOS/KOOS). However, previous
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psychometric research documents that the scores are
comparable within SF versions and between the
WOMAC and the KOOS. Finally, while this report is
based on a sample of patients from the US and
Switzerland, the respective registries have documented
that the demographics of participating patients are com-
parable to the total population with health care coverage
in these countries/regions and both cohorts include di-
verse surgeons.
Conclusion
Clinically important differences in BMI, age at surgery,
medical comorbidities, and preoperative pain and emo-
tional health as well as differences in education level
were observed between the US and Swiss cohorts before
primary total knee and hip arthroplasty. The level of
functional impairment at the time of TKA and THA
reflected significant disability in both countries. The
observed differences may result in differences in clinical
outcomes, and complication and revision rates. Cross-
cultural comparisons of TJA outcomes should consider
risk-adjustment for these variables prior to making
conclusions about apparent differences in outcome.
Future studies will evaluate post-TJA outcomes and test
the role of risk-adjustment prior to making these
comparisons.
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